Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-Y Reginster

Showing results (41-50 of 394) with videos related to

Pageof 40
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 8, 2009
Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic womenM Hiligsmann, O Bruyère, J-Y Reginster
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 10, 2010
Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regressionV Rabenda, O Bruyère, J-Y Reginster
Calcified Tissue International|December 1, 1985
Salmon-calcitonin nasal spray in Paget's disease of bone: preliminary results in five patientsJ Y Reginster, A Albert, P Franchimont
Rheumatology (Oxford, England)|April 3, 2007
Current role of glucosamine in the treatment of osteoarthritisJ-Y Reginster, O Bruyere, A Neuprez
Revue Medicale De Liege|September 6, 2008
[Long-term risk of osteoporotic fracture in Belgium]M Hiligsmann, O Bruyère, J Y Reginster
Journal of Musculoskeletal & Neuronal Interactions|September 21, 2005
The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fracturesE Schacht, F Richy, J-Y Reginster
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 1, 2008
European regulatory perspectives for innovative therapiesS Ormarsdottir, J Y Reginster, E Abadie
Bulletin of the World Health Organization|November 6, 2001
Secular increase in the incidence of hip fractures in Belgium between 1984 and 1996: need for a concerted public health strategyJ Y Reginster, P Gillet, C Gosset
Revue Medicale De Liege|August 29, 2001
[What is the role of aceclofenac in the therapeutic arsenal against chronic osteoarthritis pathologies?]J Y Reginster, I Paul, Y Henrotin
British Journal of Rheumatology|April 1, 1996
A double-blind, three-week study to compare the efficacy and safety of meloxicam 7.5 mg and meloxicam 15 mg in patients with rheumatoid arthritisJ Y Reginster, M Distel, E Bluhmki
Pageof 40

Showing results (41-50 of 394) with videos related to

Sort By:
Pageof 40
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 8, 2009
Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic womenM Hiligsmann, O Bruyère, J-Y Reginster
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 10, 2010
Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regressionV Rabenda, O Bruyère, J-Y Reginster
Calcified Tissue International|December 1, 1985
Salmon-calcitonin nasal spray in Paget's disease of bone: preliminary results in five patientsJ Y Reginster, A Albert, P Franchimont
Rheumatology (Oxford, England)|April 3, 2007
Current role of glucosamine in the treatment of osteoarthritisJ-Y Reginster, O Bruyere, A Neuprez
Revue Medicale De Liege|September 6, 2008
[Long-term risk of osteoporotic fracture in Belgium]M Hiligsmann, O Bruyère, J Y Reginster
Journal of Musculoskeletal & Neuronal Interactions|September 21, 2005
The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fracturesE Schacht, F Richy, J-Y Reginster
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 1, 2008
European regulatory perspectives for innovative therapiesS Ormarsdottir, J Y Reginster, E Abadie
Bulletin of the World Health Organization|November 6, 2001
Secular increase in the incidence of hip fractures in Belgium between 1984 and 1996: need for a concerted public health strategyJ Y Reginster, P Gillet, C Gosset
Revue Medicale De Liege|August 29, 2001
[What is the role of aceclofenac in the therapeutic arsenal against chronic osteoarthritis pathologies?]J Y Reginster, I Paul, Y Henrotin
British Journal of Rheumatology|April 1, 1996
A double-blind, three-week study to compare the efficacy and safety of meloxicam 7.5 mg and meloxicam 15 mg in patients with rheumatoid arthritisJ Y Reginster, M Distel, E Bluhmki
Pageof 40